BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Grivei A, Giuliani KT, Wang X, Ungerer J, Francis L, Hepburn K, John GT, Gois PF, Kassianos AJ, Healy H. Oxidative stress and inflammasome activation in human rhabdomyolysis-induced acute kidney injury. Free Radical Biology and Medicine 2020;160:690-5. [DOI: 10.1016/j.freeradbiomed.2020.09.011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Paul Owens E, Grania Healy H, Andrew Vesey D, Elizabeth Hoy W, Carolyn Gobe G. Targeted biomarkers of progression in chronic kidney disease. Clin Chim Acta 2022:S0009-8981(22)01283-9. [PMID: 36041551 DOI: 10.1016/j.cca.2022.08.025] [Reference Citation Analysis]
2 Luo S, Yang M, Han Y, Zhao H, Jiang N, Li L, Chen W, Li C, Yang J, Liu Y, Liu C, Zhao C, Sun L. β-Hydroxybutyrate against Cisplatin-Induced acute kidney injury via inhibiting NLRP3 inflammasome and oxidative stress. Int Immunopharmacol 2022;111:109101. [PMID: 35940076 DOI: 10.1016/j.intimp.2022.109101] [Reference Citation Analysis]
3 Madkour AH, Helal MG, Said E, Salem HA. Dose-dependent renoprotective impact of Lactoferrin against glycerol-induced rhabdomyolysis and acute kidney injury. Life Sci 2022;:120646. [PMID: 35595070 DOI: 10.1016/j.lfs.2022.120646] [Reference Citation Analysis]
4 Ying Y, Tang Q, Han D, Mou S. Nucleic Acid Nanotechnology for Diagnostics and Therapeutics in Acute Kidney Injury. IJMS 2022;23:3093. [DOI: 10.3390/ijms23063093] [Reference Citation Analysis]
5 Wang Y, Liu S, Liu Q, Lv Y. The Interaction of Central Nervous System and Acute Kidney Injury: Pathophysiology and Clinical Perspectives. Front Physiol 2022;13:826686. [DOI: 10.3389/fphys.2022.826686] [Reference Citation Analysis]
6 Aranda-rivera AK, Srivastava A, Cruz-gregorio A, Pedraza-chaverri J, Mulay SR, Scholze A. Involvement of Inflammasome Components in Kidney Disease. Antioxidants 2022;11:246. [DOI: 10.3390/antiox11020246] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
7 Zhao Y, Pu M, Wang Y, Yu L, Song X, He Z. Application of nanotechnology in acute kidney injury: From diagnosis to therapeutic implications. J Control Release 2021;336:233-51. [PMID: 34171444 DOI: 10.1016/j.jconrel.2021.06.026] [Reference Citation Analysis]
8 Li JK, Yang C, Su Y, Luo JC, Luo MH, Huang DL, Tu GW, Luo Z. Mesenchymal Stem Cell-Derived Extracellular Vesicles: A Potential Therapeutic Strategy for Acute Kidney Injury. Front Immunol 2021;12:684496. [PMID: 34149726 DOI: 10.3389/fimmu.2021.684496] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]